Time to deterioration of patient-reported outcomes in non-small cell lung cancer: exploring different definitions

PURPOSE: The clinical relevance of different time-to-deterioration (TTD) definitions for patient-reported outcomes were explored. METHODS: TTD definitions differing by reference score and deterioration event were used to analyse data from the phase 3 FLAURA trial of first-line osimertinib versus erl...

Descripción completa

Detalles Bibliográficos
Autores principales: Walding, Andrew, Skaltsa, Konstantina, Casamayor, Montserrat, Rydén, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250481/
https://www.ncbi.nlm.nih.gov/pubmed/35099678
http://dx.doi.org/10.1007/s11136-022-03088-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250481/
https://www.ncbi.nlm.nih.gov/pubmed/35099678
http://dx.doi.org/10.1007/s11136-022-03088-0

Ejemplares similares